Loading page content
Preparing content…
SOC 29-1051 · O*NET 29-1051.00
Pharmacists (O*NET 29-1051.00) review prescriptions for accuracy and appropriateness, verify patient information, allergy history, drugs, and directions, dispense or supervise dispensing, perform the final check, explain medication information to patients, and communicate anomalies to the care team. The specific scope of practice, prescription review, and dispensing authority are determined by local law, licences, and organizational policy; this page does not provide individual treatment advice.
Model impact index for three equally weighted representative core tasks; not a measured share of working time or a job-loss probability. floor((50+75+50)/3+0.5)=58; fermatmind-ai-impact-v1; 2026-10-18.
Next, verify the target jurisdiction's pharmacy education, licences, hospital or retail institutional training, and role authority; a fictional exercise does not represent clinical judgment or real prescription review.
The United States 2025 pharmacist annual median is 140,910 dollars; 2025—2035 shows a net gain of 17.1 thousand, 5.2% growth, and 12.5 thousand average annual openings including replacements. In China, hospital primary level and independent drug retail conditionally reference the industry pre-tax annual average by real main business, while this occupation's percentiles and complete quotes are still missing.
Suits people willing to examine prescriptions and patient information closely, explain the boundaries of medication use, communicate with the clinical team, and stop release when information is incomplete. If you pursue only dispensing speed, practice risk verification first.
The O*NET United States occupational classification is not the same as China's licensed pharmacist or pharmacy professional title; eligibility and prescribing authority are verified separately.
Pharmacists review prescriptions and patient data, verify the drug, dose, directions, and interactions, and dispense, verify, counsel, and maintain records within authorization.
O*NET lists reviewing prescription accuracy and appropriateness, collaborating with medical staff to evaluate drug regimens, drug quality and records, patient counselling, and pharmacy management. Actual duties in different settings are determined by authorization.
Career direction comparison
Compare drugs, patients, pharmaceutical judgment, prescribing, and licence scope; a similar occupational name does not mean mutual recognition of qualifications.
| Career direction | Core work and output | Key differences | Best-fit choice |
|---|---|---|---|
| Pharmacy technicians | Measure, compound, count, label, and record per the prescription, preparing medication under pharmacist direction. | Technical tasks are completed under pharmacist direction and do not automatically grant pharmaceutical appropriateness judgment or final release authority. | Editorial advice: those who prefer dispensing, inventory, and record processes can compare, with eligibility and supervision scope verified separately. |
| Physician assistants | Provide examinations, treatment, and patient counselling and produce treatment records; specific prescribing authority is verified by jurisdiction. |
AI impact on this career
Insufficient evidence: no verified pharmacist generative AI adoption rate, overall substitution rate, or disappearance year. The ASHP 2025 report that nearly three quarters of surveyed hospitals use EHR automatic verification for some orders involves rule-based algorithms and cannot be taken as a pharmacist GenAI adoption rate or general exemption from review. Prescription review and patient medication responsibility are verified per jurisdiction and organizational policy. AI Impact Score 58% is an editorial estimate. Model impact index for three equally weighted representative core tasks; not a measured share of working time or a job-loss probability. floor((50+75+50)/3+0.5)=58; fermatmind-ai-impact-v1; 2026-10-18.The three tasks, ratings and sources are listed in the FermatMind method source record on this page.
FermatMind AI Impact Score estimation method v1
FermatMind / 费马测试 · 2026-10-18
Editorial ratings use the existing occupational responsibilities and AI task analysis on this page. They are not adoption rates, measured effects, job-disappearance or personal-unemployment probabilities, or official scores from Stanford or another external institution. No measured time weights or future robot deployment are assumed.
Chinese mainland salary reference
First verify the pharmacy professional title, licensed registration, and institutional duties; wage statistics do not issue qualifications, and a United States degree and state licence do not directly apply in China.
Chinese pharmacy professional titles, medical institution prescription review conditions, and licensed pharmacist registration are verified separately; United States 29-1051 and the Pharm.D. are not automatically mutually recognized.
Non-private 146,266 / private 75,631 yuan/year, the health and social work multi-occupation pre-tax annual average, not a city pharmacist monthly wage.
Non-private 135,749 / private 69,622 yuan/year, the wholesale and retail multi-occupation pre-tax annual average, not a pharmacist role range.
United States wage reference
The 2025 United States national pharmacist annual wage median is 140,910 dollars; 2025—2035 shows a net gain of 17.1 thousand, 5.2% growth, and 12.5 thousand average annual openings including replacements. Not this occupation's AI causal effect, Chinese market, or an individual income forecast.
| Wage statistical position | Annual wage reference | Conversion boundaries | How to understand this position |
|---|---|---|---|
| 10th percentile | 99,290 dollars/year (10th percentile) | Official annual wage, not personal monthly income | 10th percentile 99,290 dollars/year, not a uniform entry-level or new-hire starting wage. |
| Median (50%) | 140,910 dollars/year | Official annual wage, not personal take-home pay |
Occupational fit guide
Fit looks at whether you can examine prescription versions, allergies, and drug information closely, handle interruptions, explain the unknown, and pause within authority. Use the fictional A1—A5 to observe behavior without producing a fit score.
You may be better suited to： Willing to verify patient identity, prescription versions, allergies, and drug information.
These situations need caution： If you tend to omit verification for speed, practice stopping release and communicating first.
Do one entry-level exercise： Use the fictional A1—A5 prescription to make the evidence and clarification list.
Work pressure, risk, and occupational boundaries
The six key risks are patient identity mismatch, missing allergy information, wrong drug or dose, missed interactions, misread labels, and failed review handover; when information is unclear, pause release and communicate to clarify.
O*NET supports prescription review, counselling, and record tasks; Chinese prescription review standards support medical institution processes; the risk ranking and paper cases are editorial synthesis.
Typical scenario：The patient code and the prescription page disagree.
Roles most affected：Patient and pharmacy team
Possible consequence：May hand the drug to the wrong patient.
How to reduce risk：Pause release and verify identity and the original prescription.
Entry, eligibility, and career development
Start with pharmacy education and supervised practice, practicing patient information, prescription, drug, and risk verification; after obtaining the target jurisdiction's licence, work must still follow institutional role authority.
Occupational outlook and related career moves
United States 29-1051 independent 2025 employment 325.2 to 342.3 thousand in 2035, a net gain of 17.1 thousand, 5.2% growth, 12.5 thousand average annual openings including replacement of departures and retirements, and 0.3% self-employed; overall employment is not AI's effect or Chinese demand. Hospital, outpatient, and retail directions differ, and national growth cannot be used to infer that every institution is expanding hiring.
United States · United States 29-1051 independent occupation
325.2 thousand (2025) → 342.3 thousand (2035)
Employment scale for this occupation
2025 employment 325.2 thousand, 2035 employment 342.3 thousand; net gain 17.1 thousand.
Does not establish：The occupational outlook page rounds 5.2% to 5%; average annual openings include replacements.
Verify the prescription, patient information, and drug appropriateness, dispense or supervise within authorization, perform the final check, counsel, and record doubts and communications.
Technicians perform supervised tasks, while pharmacists carry pharmaceutical review and the corresponding practice responsibility. The specific division of work follows the jurisdiction and institutional rules.
Use the fictional A1—A5 to verify the prescription version, allergies, strength, and current medication gaps, and see whether you can pause release and clarify.
Choose a real task from this page for a small practice project or a conversation with someone in the field. Use the planning guides to set a date, an output and feedback questions before deciding whether to continue.
Pharmacists verify the prescription, patient data, drug, dose, route, interactions, and allergy risk, dispense or supervise dispensing within their scope of practice, perform the final check and patient counselling, and record anomalies and referrals. Authority differs across countries and between community pharmacy and hospital roles.
Do a completely fictional paper review exercise: A1—A5 gives coded patient P, prescription versions, the allergy field, drug labels, and contact details; list only the conflicts, the steps that should be paused, and who to communicate with, without giving doses or treatment advice.
Do not release the related steps when the prescription version, patient identity, allergy history, dose, route, or interactions are unclear, and contact the prescriber or supervising pharmacist per policy.
Pharmacists, pharmacy technicians, and physicians carry pharmaceutical judgment, supervised technical work, and diagnostic, treatment, and prescribing duties respectively; the jurisdiction and organizational policy are verified separately.
| Dimension | Primary track | Comparison track |
|---|---|---|
| Core purpose | Pharmacists: prescription and drug therapy appropriateness. | Technicians: supervised dispensing and record tasks. |
| Main objects and basis | Pharmacists: patient, allergies, interactions, and the final check. | Technicians: perform specified operations as required by supervision. |
| Core process | Pharmacists: prescription review—clarify—verify—counsel—record. | Physicians: diagnosis, treatment plans, and prescriptions. |
| Main outputs | Pharmacists: medication appropriateness, quality, and patient communication. | Physicians: diagnostic, treatment, and prescribing responsibility. |
| Responsible party | Pharmacists: the licence and organizational policy define the service scope. | Adjacent roles: no automatic pharmacist review authority. |
| Authority and approval | Pharmacists: verify the degree, jurisdictional licence, and role training. | Technicians or physicians: each has independent eligibility and supervision boundaries. |
| Conclusion boundaries | Compare community pharmacy, hospital, clinical pharmacy, and drug information directions. | Communication and record skills are transferable, but prescription review and pharmaceutical judgment authorization are not automatically transferable. |
Clarify missing items first.
Do not release on guesswork.
Leave a record of key steps.
Return doubts for verification.
Do not substitute for diagnosis.
Contact the prescriber or supervisor.
Verify whether the role involves inpatient, outpatient, retail, clinical counselling, or specialty drugs.
Identity: do the patient and prescription correspond.
Drug: do the name, strength, route, and label agree.
Interactions: is a complete medication history and necessary information available.
Privacy: how is patient data used minimally.
Records: can review, interventions, release, and handover be traced.
| United States physician assistants diagnose and treat under the corresponding supervision and jurisdictional arrangements and may prescribe in some cases; this is not pharmacist eligibility. |
| Editorial advice: those who want to take part in examinations and treatment should compare its recognized education, jurisdictional licence, and supervision requirements. |
| Registered nurses | Assess patient health needs, develop and implement nursing plans, maintain records, and provide nursing care. | Nursing assessment, nursing plans, and nursing licences are independent of pharmaceutical review eligibility and are not mutually granted through clinical collaboration. | Editorial advice: those who prefer continuous bedside care can compare, verifying nursing education, registration, and duties. |
|---|
| Medical scientists (except epidemiologists) | Study human disease and health improvement, and may work in clinical research, research and development, and drug effect studies. | Medical research addresses disease, health, and research outcomes, and research training does not automatically confer real prescription review authority. | Editorial advice: those who prefer research design, experiments, and drug evidence can compare, with ethics, data, and training verified separately. |
|---|
| Community pharmacy pharmacist direction | Community pharmacies dispense against a valid prescription, explain verified medication information, and maintain inventory records. | Community prescription services still follow pharmaceutical eligibility and organizational policy, and retail throughput cannot replace review. | Editorial advice: those who prefer ongoing patient counselling and supply processes can compare the community direction. |
|---|
| Hospital pharmacist direction | Hospital pharmacists collaborate to verify drug regimens, supply, and patient medication data, and record interventions and clarifications. | The hospital direction involves team drug therapy data, handover, and possible night shifts; eligibility and training are verified per institution and jurisdiction. | Editorial advice: those who prefer care teams and complex drug regimen data can compare the hospital direction. |
|---|
The line between pharmacists and pharmacy technicians lies in pharmaceutical review and final responsibility; technicians usually perform specified tasks under supervision.
Both directions require review, verification, and records per jurisdiction and organizational requirements.
Task assistance may involve organizing prescription records and explanation drafts; clinical relevance, the physical drug, and the valid prescription require professional review, and technical ability does not grant practice rights.
The organization must confirm data quality, clinical rules, system validation, applicable patients and drugs, and anomaly fallback and supervision. Actual automatic verification is not the same as GenAI.
Overall employment, tool adoption, task potential, productivity, and individual unemployment are measured separately; this page has no causal estimate of net job change in this occupation caused by pharmacist GenAI.
| Work area | Task | Current change | Human control point |
|---|---|---|---|
| Prescription intake | Verify the patient and prescription version | Approved editorial trial: organize input drafts | People verify identity, prescriber source, and completeness. |
| Allergy verification | Verify known allergies and medical history | The system can prompt conflicts | People verify the real records and unrecorded information. |
| Interactions | Check current medications and prescribed drugs | Approved editorial trial: list items to be verified | Pharmacists verify clinical relevance and information gaps. |
| Drug verification | Verify the drug, strength, route, and label | Automation can compare barcodes | Authorized personnel verify the physical drug and patient. |
| Patient counselling | Provide verified medication information | Approved editorial trial: draft explanations | Pharmacists explain and refer according to the patient's understanding. |
| Review records | Write the clarification, intervention, and release basis | Approved editorial trial: summarize drafts | Pharmacists verify the source, timing, and final conclusion. |
| Privacy protection | Protect patient prescriptions and medical records | AI inputs may widen dissemination | The organization verifies minimum access and retention. |
Read the evidence separately as task descriptions, potential exposure, employer expectations, overall projections, and specific automatic verification practice; there is no single number that can be copied as this occupation's substitution rate.
Rule-based interaction alerts, barcode verification, and generative text tools are judged separately; the generative organization suggestions below are editorial trials in approved settings, not measured adoption.
AI primarily changesOrganize prescription fields and items to be verified in an approved environment, and do not write drafts back into a valid order.
Human responsibility remainsAuthorized pharmacists review the valid prescription, patient data, and clinical grounds, and contact the prescriber about missing items.
AI primarily changesBarcode automatic verification is automation; generative tools at most organize strength and label comparison drafts.
Human responsibility remainsAuthorized personnel verify the physical drug, patient, strength, route, and label, and text output cannot substitute.
AI primarily changesMay draft plain-language explanations and intervention records in an approved environment, without generating individual treatment plans.
Human responsibility remainsPharmacists verify the information source, patient understanding, and referral conditions and confirm the final record.
Both automatic verification and generative tools must distinguish institutional conditions; incomplete information or unvalidated rules cannot directly replace pharmaceutical judgment, and final responsibility is verified by jurisdiction.
Define the prescription type, patient scope, drug scope, purpose of use, and authorized verifying personnel; Chinese medical review and United States automatic verification regimes are kept separate.
Process only within the approved data and rule scope; missing allergies, weight, or medication history must not be treated as a negative result.
Review the valid prescription, clinical grounds, and physical drug; items the system flags as unreasonable or cannot review go to the pharmacist, and serious errors refuse dispensing and escalate.
Save the original version, basis, doubts, prescriber contact results, and signature records, distinguishing drafts from valid records.
Pharmaceutical review, dispensing, and counselling require the corresponding eligibility and organizational role authority; tools do not obtain prescribing or sign-off rights.
A draft may invent contraindications or omit current medications, and mistaking a generated sentence for clinical grounds can harm patients.
Control: Verify the valid prescription and authoritative clinical grounds item by item, mark items as pending, and do not automatically write back or release.
Prescriptions and medical records contain sensitive health information, and external sharing may exceed the lawful purpose and necessary scope.
Control: Handle per the jurisdiction's lawful basis, minimum necessity, and sensitive information protection; this page's exercise uses only fictional patient P and drug A.
Changes in tool rules or versions may alter alerts and missed-detection results, and old validation does not automatically apply.
Control: Keep the source, rule version, and approval records, and review changes and failure fallback per organizational requirements.
Inconsistent strength, dose, route, units, and prescription versions cause medication errors; a more recent date cannot override an unsigned status.
Control: Verify the original fields, units, prescriber sign-off, and physical label, pause on conflicts, and clarify with authorized personnel.
Explanations or dispensing instructions without professional review and sign-off leave responsibility and handover unclear.
Control: Write clearly the pharmacist, prescriber, time, what was verified and not, and the final decision; records must not be impersonated by drafts.
First practice fictional prescription version and information conflict verification; coursework and AI tools do not grant prescription review authority.
Verify the valid prescription, allergies, and drug labels; generated text is an approved draft only, and patient counselling is reviewed by authorized personnel.
Verify inpatient orders, patient data, and clinical grounds; automatic verification is limited to the organization's validated authorization scope, and anomalies and uncovered parts are handled by people.
Distinguish rule-based systems from generative tools, and record the applicable patients, drugs, validation results, and division of responsibility.
Insufficient evidence: no overall AI substitution rate was verified for this occupation. Pharmaceutical judgment, physical verification, and patient communication still depend on personnel eligibility, and task potential cannot be converted into individual unemployment probability.
Source: ILO potential exposure, O*NET tasks for this occupation, and Chinese prescription review standardsOriginal source ↗
Entry into this occupation first requires verified pharmacy education, a professional title or registration licence, institutional training, and drug and patient safety; programming may be chosen separately for specific information roles and is not a uniform prescription review qualification.
Source: BLS United States education and licensure and Chinese hospital prescription review and licensed pharmacist registration rulesOriginal source ↗
Record organization, explanation drafts, and doubt summaries in approved settings may trial generative tools; drug strength, allergy, interactions, and the valid prescription require verification against the original basis.
Source: Editorial task advice and the boundary of GPT potential, not measured pharmacist adoptionOriginal source ↗
The United States 29-1051 overall projection for 2025—2035 is 5.2% growth and a net gain of 17.1 thousand, with 12.5 thousand average annual openings including replacements; this cannot be used to infer AI-driven job gains or losses or Chinese demand.
Source: BLS independent occupation EP and OOH overall outlookOriginal source ↗
It cannot generally be replaced. United States rule-based automatic verification is limited to explicit conditions; Chinese standards require the pharmacist to hold first-line responsibility, and items the system flags as unreasonable or cannot review are reviewed by people.
Source: NIST cross-scenario governance supports only validation and supervision principles; specific Chinese prescription review standards and ASHP rule-based examples are in this segment's source register.Original source ↗
Insufficient evidence: no credible year was verified for the disappearance of pharmacist jobs; the 2023 task potential study also explicitly does not predict adoption timing.
Source: GPT potential summary and this page's evidence boundaryOriginal source ↗
First verify jurisdictional eligibility and duties, and practice the fictional A1—A5 prescription version, allergy, and strength conflicts; do not use real medical records or actual drugs for practice.
Source: NIST supports clarifying tool risk responsibility; pharmacy eligibility, the A1—A5 exercise, and Chinese standards are in the corresponding sources on this page.Original source ↗
Later use the fictional A1—A5 materials to test verification and clarification behavior; before real use of tools, verify organizational authorization, clinical grounds, patient data protection, and jurisdictional eligibility.
Insufficient evidence: no verified independent national or city percentiles for this occupation or a complete current quote covering eligibility, shift, and pay composition; historical postings are not merged to fabricate a range.
Insufficient evidence: strict national, city, hospital, or retail percentiles for this occupation are still missing, as are complete current quotes covering pay composition; the real historical postings are retained in the pathways section.
| Study or qualification stage | Common role directions | Notes and verification advice |
|---|---|---|
| Pharmacy professional study | Coursework and supervised practice | Education alone does not grant prescription review or dispensing rights; use the fictional A1—A5 to practice version, allergy, and strength gaps. |
| Medical institution dispensing roles | Drug dispensing verification and counselling | Verify the pharmacy professional title and institutional eligibility; pharmacists and above review, verify, and dispense while pharmacy assistants dispense, based on the prescription administration measures, and it cannot be generalized that pharmacy assistants have prescription review authority. |
| Medical institution prescription review | Medication appropriateness and anomaly communication | The standard requires a pharmacist professional title or above, at least 3 years of relevant prescription dispensing experience, and passing prescription review training and assessment; this is not a uniform education or wage grade. |
| Independent retail pharmacy services | Licensed pharmacist registration and role authority | The 2021 measures require practising as a licensed pharmacist after registering the qualification certificate, for a single unit, within the registered category and scope and continuing education requirements; they do not replace hospital professional titles and prescription review conditions. |
The following is a comparison of eligibility and study directions, not a unified Chinese education, wage, or promotion-year table.
841 hospitals and 842 primary level belong to health and social work, and in-house pharmacies follow the medical employer's main business and are referenced only where the legal-person scope matches.
5251 western medicine and 5252 traditional medicine retail belong to wholesale and retail, and not all pharmacist roles can be assigned to one industry.
Verified separately by the real employer main business; hospital industry averages cannot cover manufacturing, education, or research institutions.
Insufficient evidence: no verified causal quantification of generative AI's effect on Chinese pharmacist wages; use of rule-based prescription review systems does not prove a wage effect.
| 90th percentile | 174,230 dollars/year (90th percentile) | Official annual wage, not personal take-home pay | 90th percentile 174,230 dollars/year, not called a senior qualification or the highest income. |
|---|
Pay · 10th percentile：99,290 dollars/year (10th percentile)；2025 national 10th percentile, not a new-hire starting wage.；O*NET pharmacists 2025 national wages
Pay · 25th percentile：129,380 dollars/year；2025 25th percentile 129,380 dollars, not corresponding to particular seniority.；O*NET wage page
Pay · median：140,910 dollars/year；2025 annual median 140,910 dollars, not an individual quote.；O*NET wage page
Pay · 75th percentile：161,840 dollars/year；2025 75th percentile 161,840 dollars, not a licence grade.；O*NET wage page
Pay · 90th percentile：174,230 dollars/year (90th percentile)；2025 national 90th percentile, not a personal income ceiling or qualification grade.；O*NET pharmacists 2025 national wages
No. 140,910 dollars is this occupation's 2025 annual median, not a new-hire starting wage.
National hourly 10th/25th/50th/75th/90th percentiles 47.73/62.20/67.75/77.81/83.77 dollars; an annual salary is not derived directly when the individual's actual hours are unknown, and it is not converted to fill in Chinese wages.
This occupation's wage percentiles come from the O*NET reprint of the BLS2025 OEWS national line; the independent employment projection comes from EP2025—2035 and does not mix the ON historical 2024—2034.
Industry, region, shift, hours, duties, and employer contract are verified separately; national percentiles are not a clinical qualification wage table.
| Industry | Annual wage median / statistical status | How to understand this value |
|---|---|---|
| Hospitals | 157,290 dollars/year | The 2025 salaried annual wage median for this occupation in the hospital industry, not the average for all hospital staff. |
| Outpatient care services | 153,920 dollars/year | The 2025 annual wage median for this occupation in the outpatient care industry, not Chinese hospital or all clinical pharmacist wages. |
| General merchandise retail | 151,370 dollars/year | The 2025 annual wage median for this occupation in that retail industry, not automatically applied to independent pharmacies. |
| Pharmacies and drug retail | 132,940 dollars/year | The 2025 annual wage median for this occupation in pharmacy and drug retail, distinct from general merchandise retail and China's wholesale and retail all-occupation average. |
2025 hospital pharmacist 157,290 dollars, outpatient care 153,920, general merchandise retail 151,370, and pharmacy and drug retail 132,940 are this occupation's annual medians in four industry groups; personal income is not promised by employer name.
United States states require pharmacist licensure, the typical Pharm.D. includes supervised internship, and some advanced clinical directions require further training; wage percentiles are not treated as licence or seniority grades.
Region, hours, night, weekend, and holiday shifts, and hospital or community duties affect the specific contract; national statistics cannot replace the employer's pay composition and the individual's hours.
BLS 29-1051 independent occupation 2025 employment 325.2 thousand.；BLS projections table
2025 employment 325.2 to 342.3 thousand in 2035, a net gain of 17.1 thousand and 5.2% growth.；BLS pharmacists independent occupation projections
A ten-year average projection including replacement of departures and retirements, distinct from the net gain of 17.1 thousand and current hiring.；BLS pharmacists independent occupation projections
Investigative 78, social 65, and conventional 59 are higher group interests; the numbers are not accuracy rates or individual fit probabilities.
Those who lean toward research evidence, patient service, and standards verification can explore this occupation; a role group interest is not an individual qualification.
Which Holland type is closer to pharmacists?
O*NET interest code for this occupation ISC: investigative 78, social 65, conventional 59, realistic 30, enterprising 27, artistic 8. It is an occupational group task interest, not an individual hiring score.
Do not use it this way: Research, helping others, and rule-based verification can serve as exploration clues, but interest assessments cannot be used to take on real prescription review.
Test my Holland occupational interestsWhich Big Five traits are more relevant to this job?
Use caution, detail, reliability, and cooperative behavior to observe verification and clarification; this is task-oriented advice and gives no Big Five hiring threshold.
Do not use it this way: High conscientiousness still requires pharmacy training; willingness to pause, communicate, and leave a record when information is missing is more direct than a self-rated label.
See my Big Five personality traitsCan MBTI tell me whether I fit pharmacist work?
MBTI is for self-exploration only; this page has no reliable validation that a particular type suits pharmacists better and does not designate a best four-letter type.
Do not use it this way: Do not infer eligibility from introversion, extroversion, or a four-letter label; use fictional prescription conflicts to explain your verification and communication process.
Understand my MBTI preferencesCan the Enneagram tell me whether I fit this occupation?
The Enneagram can be used to reflect on behavior under pressure, but this page has no evidence that a type determines pharmacist fit or clinical performance.
Do not use it this way: Do not judge patient service ability by Enneagram type; practice whether you can stop and contact the supervisor after finding the A1 sign-off gap.
Explore my Enneagram patternsCan I be a pharmacist if I am bad at math?
Pharmacy work involves verifying units, strengths, and quantities and professional knowledge; weak math can be trained item by item, and a single IQ score does not determine qualification.
Do not use it this way: Do not use AI output in place of unit and strength verification; practice comparing the A3 fields and give no real dose advice.
Understand my intelligence and reasoning performanceDo pharmacists need high emotional intelligence?
Patient counselling and team clarification require listening, accurate explanation, and calm communication; observe behavioral samples and set no EQ threshold.
Do not use it this way: Reassurance cannot masquerade as a clinical guarantee; unknown allergies, current medications, or sign-off status must be stated and escalated.
Understand my emotional intelligenceFits better when: Likes patient communication, prescription services, and inventory and dispensing collaboration.
Watch for: Verify the licence, retail organizational policy, and throughput requirements; speed must not omit review.
Explore related career: Community pharmacy pharmacist directionFits better when: Likes collaborating with the care team and complex medication records.
Watch for: Night shifts and institutional processes are verified separately.
Explore related career: PharmacistsFits better when: Likes drug therapy assessment and patient follow-up.
Watch for: Advanced training and authority are verified by jurisdiction.
Explore related career: PharmacistsFits better when: Likes measuring, labeling, and inventory records under pharmacist direction.
Watch for: Technical qualifications differ from pharmaceutical judgment responsibility and do not automatically grant pharmacist prescription review authority.
Explore related career: Pharmacy techniciansFits better when: Likes research design, drug effects, and evidence materials, compared with the medical scientist definition.
Watch for: Research training and ethics and data permission are verified separately and do not automatically grant real prescription review authority.
Explore related career: Medical scientistsFits better when: Likes pharmacy teaching, courses, and research, as distinct from clinical mentoring within an institution.
Watch for: Verify the educational institution's role and research requirements; a teaching position does not automatically expand practice rights.
Explore related career: Postsecondary health specialties teachersMore direct than a personality label are accurate verification, caution, reliability, cooperation, and acknowledging the unknown. Use A1—A5 to explain where you pause and whom you clarify with.
Introversion does not automatically exclude patient counselling; practice short explanations of the source, the unknown, and the next step, and assess the pace of continuous contact with others.
Extroversion does not automatically guarantee safe communication; you must be able to hear allergy and current medication information clearly and retain verification, records, and privacy boundaries.
No single MBTI type best suited to pharmacists was verified; judge the next step with task samples, education, and eligibility.
O*NET ISC for this occupation, with I78/S65/C59 higher, is a group interest rather than a hiring threshold or individual success rate.
This page has no reliable estimate of personality test scores predicting pharmacist performance and produces no fit, pass rate, or eligibility determination.
First train unit and strength comparison and professional knowledge, and use the fictional A3 fields to verify conflicts; this page sets no uniform math or IQ pass mark.
Patient counselling and clinical clarification require listening and accurate expression and do not imply a required EQ score.
The Enneagram serves only as a reflection clue and does not determine pharmacist eligibility by type; observe whether you are willing to pause per A5 and hand to the supervisor.
Submit the A1 version card, the A2/A4 patient data card, the A3 drug verification card, and the A5 stop-and-handover card; keep the first and revised drafts, use the results to decide what training is needed, and do not treat them as proof of practice.
Evidence：O*NET pharmacists · nhc
Typical scenario：The allergy field is blank but the old record has a flag.
Roles most affected：Patient and prescriber
Possible consequence：May overlook a serious risk.
How to reduce risk：Verify patient data and contact the relevant person to clarify.
Evidence：O*NET pharmacists · nhc
Typical scenario：The drug strength or route disagrees with the prescription version.
Roles most affected：Patient and pharmacist
Possible consequence：May cause a medication error.
How to reduce risk：Quarantine the related drug and verify the current valid prescription.
Evidence：O*NET pharmacists · nhc
Typical scenario：Current medication information is incomplete while the system flags an interaction.
Roles most affected：Patient and clinical team
Possible consequence：The appropriateness of the drug regimen cannot be determined.
How to reduce risk：Add the medication history and hand to an authorized pharmacist for assessment.
Evidence：O*NET pharmacists · nhc
Typical scenario：The drug label and the dispensing record disagree.
Roles most affected：Patient and pharmacy staff
Possible consequence：The patient may take the medication incorrectly.
How to reduce risk：Stop delivery and double-check the label and the physical drug.
Evidence：O*NET pharmacists · nhc
Typical scenario：The clarification result was not recorded in the review handover record.
Roles most affected：Patient and next shift
Possible consequence：The next shift may duplicate or miss the problem.
How to reduce risk：Write the source, recipient, status, and final verification clearly.
Evidence：O*NET pharmacists · nhc
| Entry-level roles | What you mainly do early on | What employers usually look at | How to prove yourself without experience | How it differs from other directions |
|---|---|---|---|---|
| Pharmacy learner | Learn drugs, patient safety, and prescription review fundamentals. | Can distinguish information, inference, and practice judgment. | Fictional A1—A5 verification card. | Learning does not create dispensing authority. |
| Supervised internship | Verify patient, prescription, and drug information under supervision. | Can identify gaps and hand to the supervisor. | Fictional review and handover. | The internship scope is set by the jurisdiction and institution. |
| Pharmacists | Review, verify, and counsel per the licence and organizational policy. | Can maintain medication safety and records. | Redacted work approved for sharing. | Clinical authority is verified separately. |
| Hospital or community direction | Handle different prescription scenarios per role training. | Can collaborate, explain, and record. | Simulated processes and mentoring records. | Specialization does not automatically expand authority. |
| Pharmacy service coordination | Review quality, mentoring, and anomaly closure. | Can handle process defects and escalation. | Quality improvement records. | Management appointment is verified separately. |
BLS states that United States pharmacists typically need a Pharm.D. and state licensure; Chinese and other jurisdictional requirements are verified separately.
Verify the target region and institutional entry conditions.
Use the fictional A1—A5 to show version, allergy, strength, and current medication gaps.
Work samples do not prove the ability to review real prescriptions.
O*NET tasks include prescription review, counselling, drug quality, and care team collaboration.
Verify the real role setting and specialization.
Use a fictional handover with source, time, and recipient to show the habit of stopping release.
Real patient information must not be brought in.
You are a supervised pharmacy learner at the fictional "Qinghe Pharmacy" and only verify paper prescriptions, without handling real patients. A1: coded patient P has two prescription versions; the second is more recent but the prescriber's sign-off status is unclear.
A2: coded patient P's allergy field is blank, and an old visit summary flags "intolerance to a certain class of drugs", but the specific ingredient and reaction are unconfirmed.
A3: the shelf label of fictional drug A disagrees with the strength field of the second prescription version; this exercise provides no real drug names, doses, or directions.
A4: the patient's current medication list has not been updated, the system shows one interaction alert, and the channel to contact the prescriber is available.
A5: the fictional organizational rule requires no release when identity, the valid prescription, allergies, drug strength, or current medication information is unclear, and requires recording the doubts and handing them to supervising pharmacist Lin Lan for verification.
The unclear A1 version and sign-off, the A2 allergy to be clarified, and the A3 strength conflict all prevent release under a speed requirement.
The A4 alert does not equal a confirmed clinical problem, but requires more information and verification by the pharmacist and prescriber; write the source, time, recipient, and unresolved items clearly.
The work includes the A1—A5 evidence card, conflict list, and stop and communication path; do not write real drugs, doses, diagnoses, or treatment advice.
List the dates of the two A1 versions and the sign-off gap.
Review: a more recent date alone cannot establish validity.
List the A2 allergy flag and the A4 current medication gap.
Review: draw no clinical conclusion when information is missing.
Compare the A3 strength field conflict and the label source.
Per A5, write the pause on release, Lin Lan, and the matters to raise with the prescriber.
| Stage | What may be assessed | Observable evidence | Boundaries of use |
|---|---|---|---|
| Valid prescription | Can find that the A1 sign-off status is unclear | Write the versions to be verified and the prescriber | Do not choose a version yourself |
| Allergies and medication history | Can list the A2 and A4 gaps | Write the patient information that needs to be added | Does not substitute for clinical judgment |
| Drug strength | The A3 label and prescription disagree |
Read A1—A5 and mark the patient, prescription, and prohibited actions.
Compare the A1 prescription versions and sign-off status.
List the A2 allergy and the A4 current medication gaps.
Verify the A3 drug strength field conflict.
Write the handover note to pause release and contact Lin Lan.
Seal the first draft and check against the answer.
Submit four pieces of work and note the next pharmacy training questions.
| Eligibility / status | Who it mainly suits | Real job-search role | Whether it is a general hiring threshold | Application / registration requirements | Investment level | Important limits |
|---|---|---|---|---|---|---|
| Pharmacy professional education | Those preparing to enter pharmacy roles | The United States typically requires a Pharm.D.; for Chinese roles, verify the required major and education level against the posting | A degree does not equal independent prescription review eligibility | Verify school accreditation, coursework, and mentoring | Long-term professional study | Chinese professional titles and registration are not mutually recognized with United States state licences |
| Chinese medical institution prescription review conditions |
Typical scope：Performs paper and supervised tasks only.
Readiness evidence：Hand over the conflicts, risks, and the supervising pharmacist recipient.
Credential boundary：Learn community pharmacy fundamentals; does not obtain independent prescription review authority.
Next moves：Use the fictional A1—A5 materials to verify the version and information gaps in outpatient prescriptions, patient counselling, and retail processes.
Typical scope：Stop first and escalate when information is incomplete.
Readiness evidence：Can show supervised clarification and handover.
Credential boundary：Complete community pharmacy mentoring as required by the jurisdiction and institution.
Next moves：Verify outpatient prescriptions, patient counselling, and retail processes under supervision, recording what is verified and what is not.
Typical scope：Do not skip manual verification based on a system alert.
Readiness evidence：Record the verification, communication, and final decision.
Credential boundary：Specific prescriptions, drugs, and settings follow the licence and organizational authorization.
Next moves：Handle outpatient prescriptions, patient counselling, and retail processes per policy and report to the supervising pharmacist.
Typical scope：Escalate high-risk doubts; final handling goes to authorized personnel.
Readiness evidence：Can show improvement, training, and supervisor confirmation.
Credential boundary：Coordination is appointed by the institution, and training does not automatically expand the licence.
Next moves：Review outpatient prescriptions, patient counselling, and retail process quality and the patient safety loop.
Typical scope：Performs paper and supervised tasks only.
Readiness evidence：Hand over the conflicts, risks, and the hospital pharmacy supervisor recipient.
Credential boundary：Learn hospital pharmacy fundamentals; does not obtain independent prescription review authority.
Next moves：Use the fictional A1—A5 materials to verify inpatient order versions, drug strengths, and patient information gaps, and list the questions that need clarification with the care team.
Typical scope：Stop first and escalate when information is incomplete.
Readiness evidence：Can show supervised clarification and handover.
Credential boundary：Complete hospital pharmacy mentoring as required by the jurisdiction and institution.
Next moves：Verify inpatient orders and drug supply data under supervision, clarify doubts with the care team, and record what is verified and what is not.
Typical scope：Do not skip manual verification based on a system alert.
Readiness evidence：Record the verification, communication, and final decision.
Typical scope：Performs paper and supervised tasks only.
Readiness evidence：Hand over the conflicts, risks, and the clinical pharmacy supervisor recipient.
Credential boundary：Learn clinical pharmacy fundamentals; does not obtain independent prescription review authority.
Next moves：Use the fictional A1—A5 materials to verify the version and information gaps in drug therapy assessment, patient follow-up, and team collaboration.
Typical scope：Stop first and escalate when information is incomplete.
Readiness evidence：Can show supervised clarification and handover.
Credential boundary：Complete clinical pharmacy mentoring as required by the jurisdiction and institution.
Next moves：Verify drug therapy assessment, patient follow-up, and team collaboration under supervision, recording what is verified and what is not.
Typical scope：Do not skip manual verification based on a system alert.
Readiness evidence：Record the verification, communication, and final decision.
Can identify prescription and patient information conflicts in fictional materials.
Verify prescriptions, drugs, and records under supervision.
Review, counsel, and record within the licence and organizational authorization.
Reviews quality, mentoring, and anomaly closure, without replacing statutory responsibility.
United States · United States 29-1051 independent occupation
5.2% growth; 12.5 thousand average annual openings (including replacements)
Employment growth and openings
The independent BLS row projects 5.2% growth; OOH shows a rounded 5%.
Does not establish：12.5 thousand average annual openings including replacement of departures and retirements, distinct from the ten-year net gain of 17.1 thousand; not a current hiring count.
Chinese mainland · Occupational scope and period require separate verification
Insufficient evidence: no verified independent employment growth and openings for this occupation in China.
China occupational projection evidence status
Insufficient evidence: no verified comparable employment projection strictly corresponding to this occupation in China; the United States 5.2% is not treated as a Chinese trend.
Does not establish：China's broad industry wages cannot serve as an employment projection for this occupation.
These are capability relationships, not automatic promotions or credential waivers.
Transfers：Pharmacy environment experience is transferable.
Build next：Add drug dispensing and inventory technical processes.
View career profileTransfers：Patient communication is transferable.
Build next：Add diagnostic and treatment education and jurisdictional licensure.
View career profileTransfers：Patient safety awareness is transferable.
Build next：Add nursing education and medication administration practice.
View career profileTransfers：Drug knowledge is transferable.
Build next：Add research design and experimental methods.
View career profileTransfers：Pharmacy experience is transferable.
Build next：Editorial advice: compare health care service planning, staffing and scheduling coordination, and budgeting ability, with the formal management appointment and role qualifications verified separately and no automatic path to becoming a pharmacy head.
View career profileTransfers：Health education experience is transferable.
Build next：Add population health and program evaluation.
View career profileTransfers：Pharmacy record experience is transferable.
Build next：Editorial advice: add medical information systems and database design and analysis, and follow-up information governance capability; 29-9021 is a partial profile, and parts with insufficient materials are not fabricated.
View career profileTransfers：Professional knowledge is transferable.
Build next：Add teaching and research.
View career profileInsufficient evidence: this occupation's actual generative AI adoption and overall substitution rate are not verified. The ASHP hospital rule-based automatic verification of specific orders is not a GenAI adoption survey; pharmaceutical judgment, physical verification, and patient counselling follow the jurisdiction and institutional responsibility, and task exposure cannot be used to infer individual unemployment.
Hospital and primary care main business urban legal persons of 5 or more may conditionally reference the 2025 health and social work non-private 146266 / private 75631 yuan pre-tax annual average; independent drug retail main business uses wholesale and retail 135749/69622. Both cover many occupations and are not this occupation's percentiles. The three historical postings are listed separately, and this occupation's national and city percentiles and a complete current quote are still missing, so monthly take-home pay is not inferred.
No. 140,910 dollars is the BLS 29-1051 pharmacists 2025 annual median, not a new-hire starting wage or after-tax income.
The United States typical requirement is a Pharm.D. including internship, with state licensure and further training for some advanced clinical directions. Chinese hospital prescription review requires verifying a pharmacist professional title or above, 3 years of related dispensing, and training and assessment, while licensed pharmacist status separately requires qualification registration and continuing education; the two Chinese qualifications and the United States licence do not substitute for each other.
It differs by jurisdiction and duty. This page does not presume general prescribing authority; diagnosis, prescribing, and pharmaceutical review are divided per local law and institutional policy.
Gaps in patient identity, allergies, drug strength or directions, interactions, labels, and handover records.
The United States 2025—2035 overall projection shows 5.2% growth and a net gain of 17.1 thousand, with 12.5 thousand average annual openings including replacement of departures and retirements, which is not AI causation or Chinese demand. Adjacent pharmacy technology, physician assistant, nursing, research, health care management, community health, information, and teaching roles each have their own duties, training, and licences verified separately.
Compiled and edited by the FermatMind career content team; no line-by-line review by pharmacist practitioners was obtained.
The original access dates are retained as history; on 2026-10-12 this occupation's tasks and interests, United States wages and employment, Chinese prescription review standards and licensed registration, and the Peking University Hospital and Huangpu home for the elderly notices were verified. The Henan University link shows the position has been deleted; the classification PDF text was not obtained. The ASHP article access was restricted, so only the report returned by the official search was verified without a full-text review; the original link of the prescription administration measures could not be read, and the provisions used were checked against returns from the health commission's official search.
This occupation's ON tasks and interests, the BLS independent 2025—2035 overall projection, and 2025 national and four-industry wages; in China, a conditional reference to multi-occupation averages by hospital and primary care or independent drug retail main business, with hospital prescription review and licensed registration kept separate. The Peking University Hospital and Huangpu home for the elderly historical postings are verifiable; the original Henan University position text was not obtained this round.
Limitations：20 core and 1 supplemental insurance task; a group description, not an individual qualification or performance prediction. The old 2024 employment of 335100 and the 14200 openings over 2024—2034 are retained as history, and the current EP is listed by period.
Limitations：United States 2025 pharmacist national and four-industry salaried wages, not Chinese wages, individual after-tax pay, or a seniority-level quote. The in-degree internship and state licensure are not exempted because the employment table lists experience or OJT as None; Chinese qualifications are verified separately.
Limitations：Independently verified EP29-1051 independent 2025 employment 325.2 to 342.3 thousand in 2035, net gain 17.1 thousand, 5.2% growth, 12.5 thousand average annual openings including replacement of departures and retirements, and 0.3% self-employed; the typical requirement is a doctoral or professional degree, and no uniform related work experience and OJT listed as None do not mean no in-degree internship or state licence. Overall employment is not AI adoption, substitution, individual unemployment, or Chinese demand.
Limitations：This occupation's actual generative AI adoption, overall substitution, disappearance year, and wage and safety effects are not verified; the ASHP2025 report states that nearly 3/4 of surveyed hospitals use rule-based EHR automatic verification for specific orders, which is not this occupation's GenAI adoption rate or a general exemption from review, and the rule, patient data, and authorization supervision must be verified. The GPT2023 task potential, ILO2025 global exposure, WEF2025 employer expectations, and NIST2024 governance are not measured results for this occupation.
Limitations：Independently verified GB84 health 841 hospitals and 842 primary level belong to Q health and social work; 5251 western medicine and 5252 traditional medicine retail belong to F wholesale and retail, and hospital in-house pharmacies do not change the employer's main business. 2025 health and social work non-private 146266 / private 75631, and wholesale and retail non-private 135749 / private 69622 RMB pre-tax annual average, a conditional reference for multi-occupation urban legal persons of 5 or more, excluding the self-employed and freelance, not averaged together or extended to monthly take-home pay, with pharmaceutical manufacturing, university, and research main businesses verified separately.
Limitations：Actually verified Articles 2/3/4/5/6/7/8/9/12 of China's 2018 prescription review standards; hospitals at secondary level and above and others implement or refer accordingly, requiring a pharmacist professional title or above, 3 or more years of outpatient, emergency, or ward prescription dispensing experience, and passing prescription review training and assessment, and not to be miswritten as supervising pharmacist; the pharmacist holds first-line responsibility, the information system assists, unreasonable or un-reviewable items go to manual review, and serious errors refuse dispensing with records and reports. Articles 3/7/9/18/25 of China's 2021 registration measures cover practising after qualification registration, the single-unit category scope, and continuing education; hospital professional titles and retail registration and the United States PharmD and state licence do not substitute for each other.
Limitations：The stable ID is retained; the actual source is the prescription administration measures, not PIPL or a purchasing manager study, and it does not replace licensed pharmacist registration or a United States state licence.
Limitations：Only the labelled United States adjacent task definition; training, licences, and jurisdiction are verified separately, and it is not automatic transfer or a statistic for this occupation.
Limitations：Only the labelled United States adjacent task definition; training, licences, and jurisdiction are verified separately, and it is not automatic transfer or a statistic for this occupation.
Limitations：Only the labelled United States adjacent task definition; training, licences, and jurisdiction are verified separately, and it is not automatic transfer or a statistic for this occupation.
Limitations：20 core and 1 supplemental insurance task; a group description, not an individual qualification or performance prediction. The old 2024 employment of 335100 and the 14200 openings over 2024—2034 are retained as history, and the current EP is listed by period.
Limitations：About 1/4 globally in some exposure and a highest gradient of 3.3%, not a separate pharmacist adoption or unemployment rate.
Limitations：Not a real case, dose or treatment advice, clinical qualification, or measured adoption; the four works and seven-day plan only demonstrate learning verification behavior.
Limitations：Risk governance, not measured pharmacist safety effects, adoption rates, or Chinese prescription review authority.
Limitations：Potential task impact, not an adoption or substitution rate; does not predict development or adoption timing and provides no separate causal effect for this occupation.
Limitations：Expectations, not pharmacist GenAI adoption, actual job effects, or Chinese wage trends.
Limitations：20 core and 1 supplemental insurance task; a group description, not an individual qualification or performance prediction. The old 2024 employment of 335100 and the 14200 openings over 2024—2034 are retained as history, and the current EP is listed by period.
Limitations：The stable ID is retained; the actual source is the prescription administration measures, not PIPL or a purchasing manager study, and it does not replace licensed pharmacist registration or a United States state licence.
Limitations：Independently verified GB84 health 841 hospitals and 842 primary level belong to Q health and social work; 5251 western medicine and 5252 traditional medicine retail belong to F wholesale and retail, and hospital in-house pharmacies do not change the employer's main business. 2025 health and social work non-private 146266 / private 75631, and wholesale and retail non-private 135749 / private 69622 RMB pre-tax annual average, a conditional reference for multi-occupation urban legal persons of 5 or more, excluding the self-employed and freelance, not averaged together or extended to monthly take-home pay, with pharmaceutical manufacturing, university, and research main businesses verified separately.
Limitations：Independently verified EP29-1051 independent 2025 employment 325.2 to 342.3 thousand in 2035, net gain 17.1 thousand, 5.2% growth, 12.5 thousand average annual openings including replacement of departures and retirements, and 0.3% self-employed; the typical requirement is a doctoral or professional degree, and no uniform related work experience and OJT listed as None do not mean no in-degree internship or state licence. Overall employment is not AI adoption, substitution, individual unemployment, or Chinese demand.
Limitations：Independently verified the st=CA page United States national 2025 salaried five-level wages 99290/129380/140910/161840/174230 dollars, hourly 47.73/62.20/67.75/77.81/83.77, not the California164610 median; 10/90 are percentiles, not lower than or higher than, or entry and senior levels, and OEWS wages exclude the self-employed and are not individual after-tax income. The OOH gives this occupation's four industry medians 157290/153920/151370/132940.
Limitations：This occupation's actual generative AI adoption, overall substitution, disappearance year, and wage and safety effects are not verified; the ASHP2025 report states that nearly 3/4 of surveyed hospitals use rule-based EHR automatic verification for specific orders, which is not this occupation's GenAI adoption rate or a general exemption from review, and the rule, patient data, and authorization supervision must be verified. The GPT2023 task potential, ILO2025 global exposure, WEF2025 employer expectations, and NIST2024 governance are not measured results for this occupation.
Limitations：This occupation's actual generative AI adoption, overall substitution, disappearance year, and wage and safety effects are not verified; the ASHP2025 report states that nearly 3/4 of surveyed hospitals use rule-based EHR automatic verification for specific orders, which is not this occupation's GenAI adoption rate or a general exemption from review, and the rule, patient data, and authorization supervision must be verified. The GPT2023 task potential, ILO2025 global exposure, WEF2025 employer expectations, and NIST2024 governance are not measured results for this occupation.
Limitations：Independently verified the st=CA page United States national 2025 salaried five-level wages 99290/129380/140910/161840/174230 dollars, hourly 47.73/62.20/67.75/77.81/83.77, not the California164610 median; 10/90 are percentiles, not lower than or higher than, or entry and senior levels, and OEWS wages exclude the self-employed and are not individual after-tax income. The OOH gives this occupation's four industry medians 157290/153920/151370/132940.
Limitations：20 core and 1 supplemental insurance task; a group description, not an individual qualification or performance prediction. The old 2024 employment of 335100 and the 14200 openings over 2024—2034 are retained as history, and the current EP is listed by period.
Limitations：Independently verified GB84 health 841 hospitals and 842 primary level belong to Q health and social work; 5251 western medicine and 5252 traditional medicine retail belong to F wholesale and retail, and hospital in-house pharmacies do not change the employer's main business. 2025 health and social work non-private 146266 / private 75631, and wholesale and retail non-private 135749 / private 69622 RMB pre-tax annual average, a conditional reference for multi-occupation urban legal persons of 5 or more, excluding the self-employed and freelance, not averaged together or extended to monthly take-home pay, with pharmaceutical manufacturing, university, and research main businesses verified separately.
Limitations：Actually verified Articles 2/3/4/5/6/7/8/9/12 of China's 2018 prescription review standards; hospitals at secondary level and above and others implement or refer accordingly, requiring a pharmacist professional title or above, 3 or more years of outpatient, emergency, or ward prescription dispensing experience, and passing prescription review training and assessment, and not to be miswritten as supervising pharmacist; the pharmacist holds first-line responsibility, the information system assists, unreasonable or un-reviewable items go to manual review, and serious errors refuse dispensing with records and reports. Articles 3/7/9/18/25 of China's 2021 registration measures cover practising after qualification registration, the single-unit category scope, and continuing education; hospital professional titles and retail registration and the United States PharmD and state licence do not substitute for each other.
Limitations：Handled per lawful basis, purpose, necessity, and sensitive information protection, without calling all processing consent-only; grants no prescription review authority.
Limitations：The notice does not clarify the specific professional title, licence, shift, or pre-tax composition, and does not prove a current remaining opening or that a bachelor's degree permits independent prescription review.
Limitations：The new campus location is verified separately; pay is negotiable and the labour dispatch position carries no public institution establishment, and it has closed so it is not called still open.
Limitations：About 6500 per month for pharmacy assistants, 6700 for pharmacists, and 8000 for supervisors, verified separately by professional title; it has closed and is not a current quote, and the pre-tax components and shift are unclear.
Limitations：An adjacent definition, not this occupation's wages, automatic transfer, clinical authority, or Chinese qualifications.
Limitations：An adjacent definition, not this occupation's wages, automatic transfer, clinical authority, or Chinese qualifications.
Limitations：An adjacent definition, not this occupation's wages, automatic transfer, clinical authority, or Chinese qualifications.
Limitations：An adjacent definition, not this occupation's wages, automatic transfer, clinical authority, or Chinese qualifications.
Limitations：An adjacent definition, not this occupation's wages, automatic transfer, clinical authority, or Chinese qualifications.
Limitations：Editorial ratings use the existing occupational responsibilities and AI task analysis on this page. They are not adoption rates, measured effects, job-disappearance or personal-unemployment probabilities, or official scores from Stanford or another external institution. No measured time weights or future robot deployment are assumed.
The Chinese page explains the United States occupational scope and the boundaries of prescription review in Chinese medical institutions and does not constitute individual medication advice. A1—A5 is completely fictional and not for real patients.
MBTI (English) · Big Five (English) · MBTI (Chinese) · Big Five (Chinese)
Setting: how do the teams and services of hospitals and community pharmacies differ.
| Do not give dose advice |
| Stop and hand over | A5 explicitly requires pausing release | Write Lin Lan, the source, and the open items | A fictional exercise is not a practice licence |
|---|
| Those who intend to take on hospital and similar prescription review |
| The standard requires a pharmacist professional title or above, 3 years of related dispensing, and training and assessment |
| Implemented by the institutions listed in the standard, with other medical institutions referring to it |
| Pharmacy professional title, outpatient, emergency, or ward dispensing experience, and prescription review training and assessment |
| Professional education, experience, and role training |
| Not the same as a retail licensed pharmacist certificate; not a uniform threshold for supervising pharmacists |
| Supervised internship | Pharmacy learner | Practice prescriptions, patient information, and communication | The specific scope is set by the school and institution | Verify mentoring and privacy rules | Follow the internship arrangement | Learners do not release independently |
|---|
| United States state licensure and advanced clinical training | Those practising in the United States or in a specialized clinical direction | States require licensure; some advanced directions may involve 1—2 years of further training | State licensure must be verified, while advanced training is not required for all entry-level roles | Verify the recognized Pharm.D., examinations, internship, and state rules | Degree, internship, examinations, and possible further training | Not directly mutually recognized in China, and the EP OJT None entry does not remove the internship |
|---|
| Chinese licensed pharmacist registration | Those intending to practise as a licensed pharmacist | After obtaining the qualification and registering, practise per the unit category and scope | Staffing follows the regulations and is not a substitute for all hospital professional titles | Qualification certificate, employer consent, and continuing education; verify the specific conditions with the competent authority | Qualification study and registration continuing education | May practise only for a single registered unit, within the registered category and scope and does not automatically grant hospital prescription review authority |
|---|
| Continuing education | Practising pharmacists | Keep up with drug evidence and policy updates | Renewal requirements follow the jurisdiction | Check with the competent authority | The cycle follows local rules | Course certificates do not replace role authorization |
|---|
Insufficient evidence: no comparable quote was verified that simultaneously discloses the current validity period, specific work location, eligibility, shift, training, and pay composition in full; the notices above cannot be combined into national percentiles or an individual after-tax income. A1—A5 remain completely fictional and are not real cases from the three institutions.
Credential boundary：Specific prescriptions, drugs, and settings follow the licence and organizational authorization.
Next moves：Verify inpatient orders and drug supply per role policy, clarify doubts with the care team, and report to the hospital pharmacy supervisor.
Typical scope：Escalate high-risk doubts; final handling goes to authorized personnel.
Readiness evidence：Can show improvement, training, and supervisor confirmation.
Credential boundary：Coordination is appointed by the institution, and training does not automatically expand the licence.
Next moves：Review the process quality of inpatient order review, drug supply, and team handover, and follow up the closure of patient safety issues.
Credential boundary：Specific prescriptions, drugs, and settings follow the licence and organizational authorization.
Next moves：Handle drug therapy assessment, patient follow-up, and team collaboration per policy and report to the clinical pharmacy supervisor.
Typical scope：Escalate high-risk doubts; final handling goes to authorized personnel.
Readiness evidence：Can show improvement, training, and supervisor confirmation.
Credential boundary：Coordination is appointed by the institution, and training does not automatically expand the licence.
Next moves：Review the quality of drug therapy assessment, patient follow-up, and team collaboration and the patient safety loop.
